News & Publications
News ·
March 25, 2025
FirstWord Pharma: Eyeing precision medicines for ocular diseases, Character clinches $93M
Character Biosciences featured in FirstWord Pharma
News ·
March 25, 2025
Endpoints News: Ophthalmology startup Character Biosciences gets $93M for genetics-based approach
Character Biosciences featured in Endpoints News
News ·
March 25, 2025
Cheng: Announcing Character Bio’s Series B
Our CEO shares his thoughts on the company's next phase
News ·
March 25, 2025
Character Biosciences Raises $93 Million Series B
Funding will enable lead candidates for AMD to enter clinical trials in the next year
News ·
January 10, 2025
Character Bio Announces Collaboration with Bausch + Lomb
Collaboration seeks to transform ophthalmology with precision medicine
News ·
December 3, 2024
Dry-AMD Progression Study: Interim Results
Character Bio
No results found.
There are no results with this criteria. Try changing your search.